| DIRECT COMPETITOR COMPARISON | |
| GENZ | FOLD | RHHBY.PK | SHPGY | Industry | | Market Cap: | 13.37B | 88.32M | N/A | N/A | 97.43M | | Employees: | 11,000 | 115 | N/A | N/A | 65 | | Qtrly Rev Growth (yoy): | -8.90% | 34.50% | N/A | N/A | 19.70% | | Revenue (ttm): | 4.61B | 19.23M | N/A | N/A | 14.05M | | Gross Margin (ttm): | 72.40% | 8.04% | N/A | N/A | 63.92% | | EBITDA (ttm): | 1.63B | -53.13M | N/A | N/A | -12.30M | | Oper Margins (ttm): | 26.10% | -286.94% | N/A | N/A | -124.89% | | Net Income (ttm): | 485.70M | -53.67M | N/A | N/A | N/A | | EPS (ttm): | 1.754 | -2.374 | N/A | N/A | -0.32 | | P/E (ttm): | 28.72 | N/A | N/A | N/A | 16.41 | | PEG (5 yr expected): | 1.01 | N/A | 1.37 | 2.15 | 1.31 | | P/S (ttm): | 2.90 | 4.59 | N/A | N/A | 9.54 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.80 | 0.00% | 57.49B | 12.39 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 47.38 | 0.00% | 13.70B | 15.86 | | Genzyme Corp. | GENZ | 50.38 | 0.00% | 13.37B | 28.72 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.96 | 0.00% | 42.26B | 18.16 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 50.18 | 0.00% | 8.95B | 1024.08 | | Teva Pharmaceutical Industries Limited | TEVA | 53.27 | 0.00% | 46.93B | 48.74 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.05 | 0.00% | 3.93B | 19.10 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 12.08 | 0.00% | 3.00B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 18.30 | 0.00% | 5.59B | 112.27 | | Pfizer Inc. | PFE | 18.31 | 0.00% | 147.75B | 15.21 | | Johnson & Johnson | JNJ | 63.18 | 0.00% | 174.32B | 13.80 | | GlaxoSmithKline plc | GSK | 42.28 | 0.00% | 107.18B | 13.30 | | Sanofi-Aventis | SNY | 38.63 | 0.00% | 100.87B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.30 | 0.00% | 125.60B | 16.56 | | RHHBY.PK | 41.45 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 45.25 | 0.00% | 65.61B | 9.09 | | Abbott Laboratories | ABT | 54.24 | 0.00% | 83.90B | 14.70 | | Bristol-Myers Squibb Co. | BMY | 25.16 | 0.00% | 49.84B | 13.02 |
|
| NEWS ON DIRECT COMPETITORS | |
| • | SHPGY | | Shire moves to advance Gaucher drug
Tue 2:05pm -
at bizjournals.com | | • | SHPGY | | Biotech Stocks: Shire climbs, Pfizer falls in early trading
Tue 10:24am -
at MarketWatch | | • | SHPGY | | Shire applies for Euro approval of Gaucher drug
Tue 8:50am -
at MarketWatch | | • | SHPGY | | Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease
Tue 7:06am -
PR Newswire | | • | RHHBY.PK | | Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C
Mon, Nov 23 -
PR Newswire | | • | RHHBY.PK | | Spectrum Pharma: Zevalin Sales Ramp Up
Sun, Nov 22 -
at Seeking Alpha | | • | RHHBY.PK | | Desktop Bug Detector
Fri, Nov 20 -
at Forbes.com | | • | RHHBY.PK | | Biotech Stocks: Senate bill weighs on Allergan, Medicis
Thu, Nov 19 -
at MarketWatch | | • | SHPGY | | This Stock Is a Train Wreck
Thu, Nov 19 -
at Motley Fool | | • | RHHBY.PK | | 454 Life Sciences Unveils New Bench Top Sequencer, Significant Improvements to the Genome Sequencer FLX System Including 1,000 bp Reads for 2010
Thu, Nov 19 -
Business Wire | | • | RHHBY.PK | | New Cancer Research Tool: Roche's CIM-Plate 16 Enables Real-Time Analysis of Cell Migration on the xCELLigence System
Wed, Nov 18 -
Business Wire | | • | FOLD | | Developments for Parkinson's Disease Ignite Investor Enthusiasm
Mon, Nov 16 -
at Seeking Alpha | | • | FOLD | | Amicus Therapeutics to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 17, 2009
Thu, Nov 12 -
PR Newswire | | • | FOLD | | AMICUS THERAPEUTICS INC Financials
Tue, Nov 10 -
EDGAR Online Financials | | • | FOLD | | AMICUS THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report
Wed, Nov 4 -
EDGAR Online | | • | FOLD | | AMICUS THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
Tue, Nov 3 -
EDGAR Online | | • | FOLD | | Amicus Therapeutics Appoints Margaret G. McGlynn, R.Ph., to Board of Directors
Tue, Nov 3 -
PR Newswire | | | All Headlines for these symbols... |
|
|
|
0.16% Nasdaq 0.00%
Competitors
